AT
Amalgent Therapeutics, Inc.
Amalgent Therapeutics is a clinical-stage pain management company focused on developing safer oral pain therapeutics for the US market. The company achieves this by repurposing existing drugs into novel combination therapies. This approach aims to significantly improve the safety profile of current pain relief medications for patients facing severe pain challenges.
- Biotechnology
Updated 23 months ago
Funding
Raised to date
$250KRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Funding rounds are not available yet.
Founders
Product
Features
- Amalgent Therapeutics is a clinical-stage pain management company focused on developing safer oral pain therapeutics for the US market. The company achieves this by repurposing existing drugs into novel combination therapies. This approach aims to significantly improve the safety profile of current pain relief medications for patients facing severe pain challenges.